Summary:
- The article discusses a significant medical breakthrough involving a new gene-editing therapy (CRISPR-based) that has successfully treated patients with hereditary angioedema.
- The clinical trial results demonstrate that a single infusion can drastically reduce the frequency of painful swelling attacks by permanently silencing the gene responsible for the condition.